Published in Clin Infect Dis on July 01, 2009
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill ((BICAR-ICU)) | NCT02476253
Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg | NCT01388686
COMPLI-PICC: Study on Picclines' Complications (COMPLI-PICC) | NCT03017911
Hospital-acquired infections due to gram-negative bacteria. N Engl J Med (2010) 6.61
Explaining Michigan: developing an ex post theory of a quality improvement program. Milbank Q (2011) 4.58
Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*. Crit Care Med (2014) 3.79
Clinical management of Staphylococcus aureus bacteremia: a review. JAMA (2014) 3.29
Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis (2015) 2.71
Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis (2011) 2.62
Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol (2011) 2.25
Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Support Care Cancer (2010) 2.19
Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet (2013) 1.94
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect (2011) 1.90
Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics (2010) 1.88
Coagulase-negative staphylococci. Clin Microbiol Rev (2014) 1.85
Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov (2013) 1.82
A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother (2010) 1.77
The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med (2010) 1.73
Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr (2012) 1.72
What counts? An ethnographic study of infection data reported to a patient safety program. Milbank Q (2012) 1.68
Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol (2011) 1.50
Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol (2013) 1.46
Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study. Support Care Cancer (2014) 1.40
Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis (2011) 1.36
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc (2011) 1.33
Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med (2011) 1.32
The spectrum of infections in catheter-dependent hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.29
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care (2014) 1.25
Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. J Clin Microbiol (2010) 1.23
Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis (2011) 1.22
High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res (2012) 1.21
Standardized definitions for hemodialysis vascular access. Semin Dial (2011) 1.20
Clinical experience with daptomycin in Europe: the first 2.5 years. J Antimicrob Chemother (2011) 1.17
Strategies for combating bacterial biofilm infections. Int J Oral Sci (2015) 1.17
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
Antifungal lock therapy. Antimicrob Agents Chemother (2012) 1.16
Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One (2010) 1.15
The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation. PLoS One (2010) 1.15
Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection (2013) 1.14
Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care (2012) 1.14
Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother (2013) 1.13
Candida albicans Biofilms and Human Disease. Annu Rev Microbiol (2015) 1.11
Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience. Am J Kidney Dis (2010) 1.10
Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis (2013) 1.10
Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care (2011) 1.10
Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation. J Clin Microbiol (2013) 1.09
Tunnelled central venous catheter-related problems in the early phase of haematopoietic stem cell transplantation and effects on transplant outcome. Turk J Haematol (2015) 1.08
Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis (2014) 1.07
Comparative analysis of Candida biofilm quantitation assays. Med Mycol (2011) 1.07
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother (2012) 1.07
Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patient. J Clin Microbiol (2011) 1.05
Staphylococcus epidermidis agr quorum-sensing system: signal identification, cross talk, and importance in colonization. J Bacteriol (2014) 1.04
A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One (2012) 1.03
Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis (2009) 1.03
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother (2013) 1.02
Pseudomonas aeruginosa biofilms in disease. Microb Ecol (2013) 1.02
Quantitation of Candida CFU in initial positive blood cultures. J Clin Microbiol (2011) 1.02
The first case of catheter-related bloodstream infection caused by Nocardia farcinica. J Korean Med Sci (2010) 1.01
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. Clin Microbiol Infect (2015) 1.01
In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species. Antimicrob Agents Chemother (2011) 1.00
The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit. Crit Care (2012) 1.00
Quantifying factors for the success of stratified medicine. Nat Rev Drug Discov (2011) 1.00
Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine (Baltimore) (2013) 1.00
Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes. J Korean Med Sci (2011) 1.00
The Japanese guidelines for the management of sepsis. J Intensive Care (2014) 0.99
Ethanol causes protein precipitation--new safety issues for catheter locking techniques. PLoS One (2013) 0.96
Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer (2014) 0.95
Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob Agents Chemother (2011) 0.94
Image-guided chemoport insertion by interventional radiologists: A single-center experience on periprocedural complications. Indian J Radiol Imaging (2013) 0.94
Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis (2015) 0.94
Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother (2012) 0.93
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia. Clin Infect Dis (2014) 0.92
Clinical severity of rhinovirus/enterovirus compared to other respiratory viruses in children. Influenza Other Respir Viruses (2014) 0.92
Intravascular catheter-related bloodstream infection. Neurohospitalist (2013) 0.92
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol (2011) 0.92
Guidelines for prevention of hospital acquired infections. Indian J Crit Care Med (2014) 0.92
Seasonal trend and clinical presentation of Bacillus cereus bloodstream infection: association with summer and indwelling catheter. Eur J Clin Microbiol Infect Dis (2014) 0.91
Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults. Clin Microbiol Infect (2015) 0.91
Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol (2014) 0.90
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care (2010) 0.90
Implementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic data. Biomed Res Int (2014) 0.90
Value of superficial cultures for prediction of catheter-related bloodstream infection in long-term catheters: a prospective study. J Clin Microbiol (2013) 0.90
Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study. Antimicrob Agents Chemother (2012) 0.89
Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia. J Am Soc Nephrol (2014) 0.89
Candida biofilms and the host: models and new concepts for eradication. Int J Microbiol (2011) 0.89
Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections. Ann Clin Microbiol Antimicrob (2015) 0.89
Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants. Eur J Clin Pharmacol (2013) 0.89
Antibiotic lock therapy: review of technique and logistical challenges. Infect Drug Resist (2014) 0.89
Bacillus cereus catheter related bloodstream infection in a patient with acute lymphoblastic leukemia. Mediterr J Hematol Infect Dis (2012) 0.88
Chelating agents exert distinct effects on biofilm formation in Staphylococcus aureus depending on strain background: role for clumping factor B. J Med Microbiol (2012) 0.88
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist (2012) 0.88
A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients. Front Microbiol (2016) 0.87
Neutropenic patients and their infectious complications at a University Hospital. Rev Bras Hematol Hemoter (2013) 0.87
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit. Crit Care (2009) 0.87
Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms. Antimicrob Agents Chemother (2012) 0.87
Moraxella osloensis: an unusual cause of central venous catheter infection in a cancer patient. Int J Gen Med (2012) 0.87
Impact of random safety analyses on structure, process and outcome indicators: multicentre study. Ann Intensive Care (2017) 0.87
Molecular investigation of bacterial communities on intravascular catheters: no longer just Staphylococcus. Eur J Clin Microbiol Infect Dis (2014) 0.87
In vitro analyses of ethanol activity against Candida albicans biofilms. Antimicrob Agents Chemother (2012) 0.87
Diagnosis of Bloodstream Infections in Children. J Clin Microbiol (2016) 0.86
Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (2011) 0.86
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control (2004) 14.85
A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med (1977) 11.49
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med (2002) 9.21
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J (1979) 7.55
Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA (2005) 7.41
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis (2006) 7.36
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol (2004) 6.65
Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med (2007) 5.88
Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med (1994) 5.72
Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA (2001) 5.55
The new beta-lactamases. N Engl J Med (2005) 5.12
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 4.64
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52
The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc (2006) 4.30
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet (2001) 3.94
Prevention of intravascular catheter-related infections. Ann Intern Med (2000) 3.81
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 3.70
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med (2008) 3.67
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41
Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med (2003) 3.31
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet (2007) 3.11
Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 3.06
Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med (2001) 3.02
Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med (2004) 2.86
Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med (2006) 2.76
Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis (1980) 2.71
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis (2004) 2.67
Serratia marcescens bacteremia traced to an infused narcotic. N Engl J Med (2002) 2.66
Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med (1997) 2.65
Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis (1998) 2.61
Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol (1990) 2.61
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis (2009) 2.54
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis (1993) 2.51
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) (2003) 2.51
Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol (1997) 2.49
A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis (2007) 2.47
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2007) 2.42
Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis (1995) 2.36
Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med (2001) 2.33
Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis (2004) 2.28
Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis (2005) 2.26
Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am Heart J (2004) 2.25
Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (1996) 2.20
Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med (2005) 2.18
Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit Care Med (2007) 2.14
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis (1995) 2.11
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med (1997) 2.10
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med (1996) 2.09
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) (1988) 2.09
Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med (1991) 2.08
A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis (1997) 2.05
Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med (1987) 2.03
Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy. Clin Infect Dis (2006) 1.99
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis (1997) 1.95
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med (2001) 1.94
Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis (2005) 1.92
Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) (1995) 1.88
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med (1999) 1.83
Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet (1999) 1.83
Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis (2007) 1.81
Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med (2005) 1.80
Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. J Am Coll Cardiol (1993) 1.78
Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother (2004) 1.73
Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology (1996) 1.70
Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis (2007) 1.70
The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med (1991) 1.69
Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med (2008) 1.69
Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med (2007) 1.69
Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis (2004) 1.69
Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center. Arch Intern Med (2005) 1.69
Aqueous quaternary ammonium antiseptics and disinfectants. Use and misuse. JAMA (1976) 1.67
Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis (1992) 1.65
Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med (1995) 1.64
Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis (1995) 1.61
Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet (2000) 1.61
Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg (2001) 1.60
Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med (1999) 1.60
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis (2005) 1.59
Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Crit Care Med (2008) 1.59
Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int (2002) 1.58
Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med (2002) 1.58
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother (2006) 1.55
Catheter-related sepsis in patients on intravenous nutrition: a prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis. Br J Surg (1985) 1.54
Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics (1996) 1.53
Chlorhexidine compared with povidone-iodine as skin preparation before blood culture. A randomized, controlled trial. Ann Intern Med (1999) 1.52
Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip. J Hosp Infect (2005) 1.52
Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant (2004) 1.50
Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med (2004) 1.50
Catheter-related septic central venous thrombosis--current therapeutic options. West J Med (1986) 1.50
Difference in time to positivity of hub-blood versus nonhub-blood cultures is not useful for the diagnosis of catheter-related bloodstream infection in critically ill patients. Crit Care Med (2001) 1.49
Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol (1997) 1.48
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis (2011) 9.37
Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med (2013) 7.75
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med (2011) 7.07
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis (2007) 5.15
Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 4.64
Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control (2011) 4.59
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis (2005) 4.31
Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis (2011) 4.09
Endothelial function in HIV-infected persons. Clin Infect Dis (2006) 3.80
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis (2005) 3.14
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis (2012) 3.11
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA (2008) 3.01
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis (2011) 2.89
Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis (2011) 2.84
Bundled care for septic shock: an analysis of clinical trials. Crit Care Med (2010) 2.57
Nocardiosis at the turn of the century. Medicine (Baltimore) (2009) 2.55
Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA (2013) 2.55
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis (2009) 2.54
Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis (2011) 2.49
Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol (2006) 2.47
Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. J Neurosurg (2010) 2.42
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica (2006) 2.41
Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis (2005) 2.27
Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology (2002) 2.26
Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol (2002) 2.24
Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16
HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr (2005) 2.13
Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol (2009) 2.13
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother (2008) 2.11
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis (2013) 2.09
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09
Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis (2007) 2.07
Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis (2005) 2.06
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis (2006) 1.97
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) (2006) 1.96
Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics (2005) 1.89
Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis (2008) 1.88
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother (2003) 1.85
Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis (2010) 1.83
Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis (2007) 1.81
Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol (2010) 1.75
Vascular access stenosis: comparison of arteriovenous grafts and fistulas. Am J Kidney Dis (2004) 1.75
Needle infiltration of arteriovenous fistulae in hemodialysis: risk factors and consequences. Am J Kidney Dis (2006) 1.75
The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med (2010) 1.73
Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology. J Vasc Interv Radiol (2003) 1.70
The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis. Clin Infect Dis (2011) 1.69
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg (2008) 1.67
Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis (2005) 1.66
Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J Infect Dis (2013) 1.61
Peripherally inserted central venous catheter-associated bloodstream infections in hospitalized adult patients. Infect Control Hosp Epidemiol (2011) 1.61
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis (2010) 1.60
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med (2002) 1.60
Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center. Arch Pediatr Adolesc Med (2010) 1.59
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother (2005) 1.59
Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int (2002) 1.58
Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med (2011) 1.58
Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med (2007) 1.56
Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis (2003) 1.54
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med (2015) 1.54
Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics (2002) 1.53
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) (2003) 1.51
Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant (2004) 1.50
Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope. Am J Kidney Dis (2008) 1.50
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.50
α-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia. Am J Respir Crit Care Med (2014) 1.50
Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol (2011) 1.49
Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis (2005) 1.48
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin Infect Dis (2008) 1.48
Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol (2003) 1.47
[Late diagnosis of HIV positive patients in Rotterdam, the Netherlands: risk factors and missed opportunities]. Ned Tijdschr Geneeskd (2013) 1.47
Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer (2008) 1.46
Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J Clin Microbiol (2005) 1.45
Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics (2002) 1.44
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med (2009) 1.44
Acute renal insufficiency during telavancin therapy in clinical practice. J Antimicrob Chemother (2011) 1.43
Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int (2003) 1.42
Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment. Clin Infect Dis (2002) 1.42
Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) (2007) 1.41
Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants. Infect Control Hosp Epidemiol (2010) 1.40
Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore) (2010) 1.39
Aneurysm formation in arteriovenous grafts: associations and clinical significance. Semin Dial (2007) 1.38
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother (2002) 1.36
Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis (2007) 1.36
Percutaneous renal biopsy: comparison of blind and real-time ultrasound-guided technique. Semin Dial (2007) 1.35
Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol (2008) 1.34
Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter? Infect Control Hosp Epidemiol (2010) 1.34
Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob Agents Chemother (2004) 1.34
Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis (2009) 1.33
Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis (2006) 1.31
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin Infect Dis (2008) 1.30
Analysis of changes in recent tuberculosis transmission patterns after a sharp increase in immigration. J Clin Microbiol (2006) 1.29